Jae Kyung Myung1, Seung Ah Choi2, Seung-Ki Kim2, Kyu-Chang Wang2, Sung-Hye Park3. 1. Department of Pathology, College of Medicine, Seoul National University Hospital Seoul, Korea. 2. Division of Pediatric Neurosurgery, Pediatric Clinical Neuroscience Center, Seoul National University Children's Hospital Seoul, Korea. 3. Department of Pathology, College of Medicine, Seoul National University Hospital Seoul, Korea ; Neuroscience Institute, College of Medicine, Seoul National University Seoul, Korea.
Abstract
BACKGROUND: The factors affecting glioblastoma progression are of great clinical importance since dismal outcomes have been observed for glioblastoma patients. The Snail gene is known to coordinate the regulation of tumor progression in diverse tumors through induction of epithelial mesenchymal transition (EMT); however, its role in glioblastoma is still uncertain. Therefore, we aimed to further define its role in vitro. METHODS AND RESULTS: The small interfering RNA (siRNA) technique was employed to knock down Snail expression in three glioblastoma cell lines (KNS42, U87, and U373). Specific inhibition of Snail expression increased E-cadherin expression but decreased vimentin expression in all cell lines. In addition, inhibition of the expression of Snail significantly reduced the proliferation, viability, invasion, and migration of glioblastoma cells as well as increased the number of cells in the G1 phase. CONCLUSIONS: Knockdown of Snail suppresses the proliferation, viability, migration, and invasion of cells as well as inhibits cell cycle progression by promoting EMT induction. The findings suggest that expression of this gene facilitates glioblastoma progression. Therefore, these results indicate the clinical significance of Snail for use as a potential therapeutic target for glioblastoma.
BACKGROUND: The factors affecting glioblastoma progression are of great clinical importance since dismal outcomes have been observed for glioblastomapatients. The Snail gene is known to coordinate the regulation of tumor progression in diverse tumors through induction of epithelial mesenchymal transition (EMT); however, its role in glioblastoma is still uncertain. Therefore, we aimed to further define its role in vitro. METHODS AND RESULTS: The small interfering RNA (siRNA) technique was employed to knock down Snail expression in three glioblastoma cell lines (KNS42, U87, and U373). Specific inhibition of Snail expression increased E-cadherin expression but decreased vimentin expression in all cell lines. In addition, inhibition of the expression of Snail significantly reduced the proliferation, viability, invasion, and migration of glioblastoma cells as well as increased the number of cells in the G1 phase. CONCLUSIONS: Knockdown of Snail suppresses the proliferation, viability, migration, and invasion of cells as well as inhibits cell cycle progression by promoting EMT induction. The findings suggest that expression of this gene facilitates glioblastoma progression. Therefore, these results indicate the clinical significance of Snail for use as a potential therapeutic target for glioblastoma.
Authors: Héctor G Pálmer; María Jesús Larriba; José Miguel García; Paloma Ordóñez-Morán; Cristina Peña; Sandra Peiró; Isabel Puig; Rufo Rodríguez; Ricardo de la Fuente; Antonio Bernad; Marina Pollán; Félix Bonilla; Carlos Gamallo; Antonio García de Herreros; Alberto Muñoz Journal: Nat Med Date: 2004-08-22 Impact factor: 53.440
Authors: Jose M Ayuso; Rosa Monge; Alicia Martínez-González; María Virumbrales-Muñoz; Guillermo A Llamazares; Javier Berganzo; Aurelio Hernández-Laín; Jorge Santolaria; Manuel Doblaré; Christopher Hubert; Jeremy N Rich; Pilar Sánchez-Gómez; Víctor M Pérez-García; Ignacio Ochoa; Luis J Fernández Journal: Neuro Oncol Date: 2017-04-01 Impact factor: 12.300
Authors: Lee Admoni-Elisha; Tzofit Elbaz; Anand Chopra; Guy Shapira; Mark T Bedford; Christopher J Fry; Noam Shomron; Kyle Biggar; Michal Feldman; Dan Levy Journal: Nucleic Acids Res Date: 2022-06-13 Impact factor: 19.160
Authors: F Volpin; J Casaos; J Sesen; A Mangraviti; J Choi; N Gorelick; J Frikeche; T Lott; R Felder; S J Scotland; T S K Eisinger-Mathason; H Brem; B Tyler; N Skuli Journal: Oncogene Date: 2016-12-12 Impact factor: 9.867
Authors: Eric C Woolf; Kara L Curley; Qingwei Liu; Gregory H Turner; Julie A Charlton; Mark C Preul; Adrienne C Scheck Journal: PLoS One Date: 2015-06-17 Impact factor: 3.240
Authors: C Depner; H Zum Buttel; N Böğürcü; A M Cuesta; M R Aburto; S Seidel; F Finkelmeier; F Foss; J Hofmann; K Kaulich; S Barbus; M Segarra; G Reifenberger; B K Garvalov; T Acker; A Acker-Palmer Journal: Nat Commun Date: 2016-07-29 Impact factor: 14.919